InsiderTrades.com logo

NMRA Insider Trading

Insider Ownership Percentage: 26.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,407,295.60

Neumora Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Neumora Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Neumora Therapeutics Share Price & Price History

Current Price: $1.28
Price Change: ▼ Price Decrease of -0.12 (-8.57%)
As of 03/14/2025 05:00 PM ET

This chart shows the closing price history over time for NMRA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Neumora Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/18/2025Joshua PintoPresidentSell8,048$1.67$13,440.1676,952View SEC Filing Icon  
2/18/2025Michael Lee MilliganInsiderSell1,978$1.69$3,342.8222,470View SEC Filing Icon  
10/18/2024Matthew K FustDirectorSell14,049$17.03$239,254.4720,100View SEC Filing Icon  
10/9/2024Robert A LenzInsiderSell5,563$15.01$83,500.63322,966View SEC Filing Icon  
9/17/2024Robert A LenzInsiderSell30,788$11.81$363,606.28339,205View SEC Filing Icon  
8/26/2024Joshua PintoCFOSell31,642$11.78$372,742.76154,658View SEC Filing Icon  
8/22/2024Joshua PintoCFOSell28,496$11.63$331,408.48210,469View SEC Filing Icon  
11/14/2023Arch Venture Partners Xii, LlcMajor ShareholderBuy3,357$11.98$40,216.864,131,207View SEC Filing Icon  
11/13/2023Kristina BurowDirectorBuy31,653$11.75$371,922.754,127,850View SEC Filing Icon  
11/10/2023Kristina BurowDirectorBuy17,275$11.49$198,489.754,096,197View SEC Filing Icon  
11/9/2023Arch Venture Partners Xii, LlcMajor ShareholderBuy31,079$10.53$327,261.874,078,922View SEC Filing Icon  
11/8/2023Kristina BurowDirectorBuy92,251$11.03$1,017,528.534,047,843View SEC Filing Icon  
11/7/2023Arch Venture Partners Xii, LlcMajor ShareholderBuy30,192$11.50$347,208.003,955,592View SEC Filing Icon  
11/6/2023Kristina BurowDirectorBuy43,082$11.55$497,597.103,925,400View SEC Filing Icon  
11/3/2023Kristina BurowDirectorBuy22,420$11.38$255,139.603,882,318View SEC Filing Icon  
9/29/2023Arch Venture Partners Xii, LlcMajor ShareholderBuy34,560$13.98$483,148.803,859,898View SEC Filing Icon  
9/28/2023Kristina BurowDirectorBuy41,951$13.44$563,821.443,825,338View SEC Filing Icon  
9/27/2023Arch Venture Partners Xii, LlcMajor ShareholderBuy24,504$12.31$301,644.243,783,387View SEC Filing Icon  
9/26/2023Kristina BurowDirectorBuy34,000$11.73$398,820.003,758,883View SEC Filing Icon  
9/25/2023Arch Venture Partners Xii, LlcMajor ShareholderBuy60,740$11.22$681,502.803,724,883View SEC Filing Icon  
9/22/2023Arch Venture Partners Xii, LlcMajor ShareholderBuy40,000$11.14$445,600.003,664,143View SEC Filing Icon  
9/19/2023Amgen IncMajor ShareholderBuy1,764,705$17.00$29,999,985.0035,368,653View SEC Filing Icon  
9/19/2023Henry O GosebruchCEOBuy15,000$12.62$189,300.0015,000View SEC Filing Icon  
9/19/2023Kristina BurowDirectorBuy1,500,000$17.00$25,500,000.003,624,143View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Neumora Therapeutics (NASDAQ:NMRA)

47.65% of Neumora Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NMRA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Neumora Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/26/2025Windmill Hill Asset Management Ltd104,373$1.11M0.4%+299.6%0.065%Search for SEC Filing on Google Icon
2/17/2025UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC72,622$0.77M0.0%N/A0.045%Search for SEC Filing on Google Icon
2/17/2025Wexford Capital LP252,122$2.67M0.4%+15.7%0.156%Search for SEC Filing on Google Icon
2/17/2025Toronto Dominion Bank34,300$0.36M0.0%N/A0.021%Search for SEC Filing on Google Icon
2/17/2025Stempoint Capital LP428,137$4.54M1.1%N/A0.265%Search for SEC Filing on Google Icon
2/17/2025Softbank Group CORP.6,541,190$69.34M0.3%-13.3%4.049%Search for SEC Filing on Google Icon
2/17/2025Rafferty Asset Management LLC17,431$0.19M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/17/2025Numerai GP LLC51,696$0.55M0.2%+46.7%0.032%Search for SEC Filing on Google Icon
2/17/2025Orbimed Advisors LLC804,996$8.53M0.2%-46.3%0.498%Search for SEC Filing on Google Icon
2/17/2025Janus Henderson Group PLC26,500$0.28M0.0%N/A0.016%Search for SEC Filing on Google Icon
2/17/2025Graham Capital Management L.P.66,669$0.71M0.0%N/A0.041%Search for SEC Filing on Google Icon
2/17/2025Deutsche Bank AG73,103$0.78M0.0%+50.4%0.045%Search for SEC Filing on Google Icon
2/17/2025Cutter Capital Management LP150,000$1.59M0.7%N/A0.093%Search for SEC Filing on Google Icon
2/17/2025Brevan Howard Capital Management LP80,559$0.85M0.0%N/A0.050%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets20,885$0.22M0.0%N/A0.013%Search for SEC Filing on Google Icon
2/17/2025Ameriprise Financial Inc.118,674$1.26M0.0%N/A0.073%Search for SEC Filing on Google Icon
2/14/2025PDT Partners LLC25,023$0.27M0.0%-20.1%0.015%Search for SEC Filing on Google Icon
2/14/2025Schonfeld Strategic Advisors LLC521,013$5.52M0.0%+273.9%0.322%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp734,847$7.79M0.0%+7.7%0.455%Search for SEC Filing on Google Icon
2/14/2025The Manufacturers Life Insurance Company 45,060$0.48M0.0%-59.0%0.028%Search for SEC Filing on Google Icon
2/14/2025T. Rowe Price Investment Management Inc.5,002,799$53.03M0.0%-4.3%3.097%Search for SEC Filing on Google Icon
2/14/2025Price T Rowe Associates Inc. MD32,548$0.35M0.0%-94.8%0.020%Search for SEC Filing on Google Icon
2/14/2025Soros Capital Management LLC279,333$2.96M0.5%-45.1%0.173%Search for SEC Filing on Google Icon
2/14/2025Rock Springs Capital Management LP955,106$10.12M0.4%+15.3%0.591%Search for SEC Filing on Google Icon
2/14/2025Capital International Investors3,700,359$39.22M0.0%+692.1%2.290%Search for SEC Filing on Google Icon
2/13/2025PEAK6 LLC11,057$0.12M0.0%N/A0.007%Search for SEC Filing on Google Icon
2/13/2025XTX Topco Ltd21,838$0.23M0.0%N/A0.014%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC166,822$1.77M0.0%+29.1%0.103%Search for SEC Filing on Google Icon
2/13/2025Legal & General Group Plc59,842$0.63M0.0%+526.4%0.037%Search for SEC Filing on Google Icon
2/13/2025Invesco Ltd.49,249$0.52M0.0%+254.1%0.030%Search for SEC Filing on Google Icon
2/13/2025ADAR1 Capital Management LLC68,608$0.73M0.1%N/A0.042%Search for SEC Filing on Google Icon
2/13/2025Wells Fargo & Company MN70,653$0.75M0.0%+23.0%0.044%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC1,970,280$20.89M0.0%-0.5%1.220%Search for SEC Filing on Google Icon
2/12/2025Franklin Resources Inc.31,357$0.33M0.0%-58.6%0.019%Search for SEC Filing on Google Icon
2/12/2025Alliancebernstein L.P.199,947$2.12M0.0%-10.3%0.124%Search for SEC Filing on Google Icon
2/12/2025Norges Bank110,000$1.17M0.0%N/A0.068%Search for SEC Filing on Google Icon
2/11/2025EntryPoint Capital LLC12,762$0.14M0.1%N/A0.008%Search for SEC Filing on Google Icon
2/11/2025Vanguard Group Inc.4,572,308$48.47M0.0%+4.5%2.830%Search for SEC Filing on Google Icon
2/11/2025KLP Kapitalforvaltning AS13,500$0.14M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/11/2025Quantbot Technologies LP8,646$92K0.0%N/A0.005%Search for SEC Filing on Google Icon
2/11/2025Teacher Retirement System of Texas16,669$0.18M0.0%N/A0.010%Search for SEC Filing on Google Icon
2/10/2025Swiss National Bank110,200$1.17M0.0%N/A0.068%Search for SEC Filing on Google Icon
2/7/2025PNC Financial Services Group Inc.6,000$64K0.0%N/A0.004%Search for SEC Filing on Google Icon
2/7/2025AMG National Trust Bank43,379$0.48M0.0%N/A0.027%Search for SEC Filing on Google Icon
2/7/2025Candriam S.C.A.571,027$6.05M0.0%-15.6%0.353%Search for SEC Filing on Google Icon
2/6/2025Arizona State Retirement System16,222$0.17M0.0%N/A0.010%Search for SEC Filing on Google Icon
2/6/2025Charles Schwab Investment Management Inc.704,154$7.46M0.0%+0.8%0.436%Search for SEC Filing on Google Icon
2/3/2025Callan Capital LLC636,194$6.74M0.5%-3.8%0.394%Search for SEC Filing on Google Icon
2/3/2025Ieq Capital LLC36,853$0.39M0.0%-50.8%0.023%Search for SEC Filing on Google Icon
1/31/2025Addis & Hill Inc163,386$1.73M1.3%-45.5%0.101%Search for SEC Filing on Google Icon
1/28/2025Windmill Hill Asset Management Ltd104,373$1.11M1.1%+299.6%0.065%Search for SEC Filing on Google Icon
1/27/2025Mirae Asset Global Investments Co. Ltd.5,384$61K0.0%N/A0.003%Search for SEC Filing on Google Icon
1/24/2025SkyOak Wealth LLC20,000$0.21M0.0%+33.3%0.012%Search for SEC Filing on Google Icon
1/24/2025China Universal Asset Management Co. Ltd.34,257$0.36M0.0%N/A0.021%Search for SEC Filing on Google Icon
1/17/2025SG Americas Securities LLC14,119$0.15M0.0%-34.6%0.009%Search for SEC Filing on Google Icon
12/26/2024JPMorgan Chase & Co.64,421$0.85M0.0%+2.6%0.040%Search for SEC Filing on Google Icon
11/27/2024Franklin Resources Inc.75,702$1M0.0%-13.9%0.047%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC129,210$1.71M0.0%+352.9%0.080%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,979,847$26.16M0.0%+54.0%1.225%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC129,210$1.71M0.0%+352.9%0.080%Search for SEC Filing on Google Icon
11/15/2024Wexford Capital LP217,879$2.88M0.7%+90.1%0.135%Search for SEC Filing on Google Icon
11/15/2024State Street Corp1,790,707$23.66M0.0%+65.3%1.108%Search for SEC Filing on Google Icon
11/15/2024Quarry LP5,000$66K0.0%-50.0%0.003%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.83,077$1.10M0.0%N/A0.051%Search for SEC Filing on Google Icon
11/13/2024FMR LLC7,749,156$102.37M0.0%-10.1%4.842%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company109,802$1.45M0.0%-1.8%0.069%Search for SEC Filing on Google Icon
11/12/2024Cerity Partners LLC242,900$3.21M0.0%N/A0.152%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.698,255$9.22M0.0%+139.7%0.436%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC13,275$0.18M0.0%N/A0.008%Search for SEC Filing on Google Icon
10/30/2024Auour Investments LLC250,000$3.30M1.2%N/A0.156%Search for SEC Filing on Google Icon
10/23/2024Ballentine Partners LLC13,441$0.18M0.0%N/A0.008%Search for SEC Filing on Google Icon
10/9/2024Clarius Group LLC16,992$0.22M0.0%N/A0.011%Search for SEC Filing on Google Icon
10/5/2024Handelsbanken Fonder AB26,600$0.35M0.0%+35.0%0.017%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC21,581$0.29M0.0%-62.5%0.014%Search for SEC Filing on Google Icon
8/27/2024Logos Global Management LP300,000$2.95M0.2%-21.5%0.188%Search for SEC Filing on Google Icon
8/16/2024Quarry LP10,000$98K0.0%N/A0.006%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company111,828$1.10M0.0%+79.5%0.070%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP134,545$1.32M0.0%N/A0.084%Search for SEC Filing on Google Icon
8/14/2024Logos Global Management LP300,000$2.95M0.2%-21.5%0.188%Search for SEC Filing on Google Icon
8/13/2024Callan Capital LLC661,194$6.50M0.5%+222.6%0.414%Search for SEC Filing on Google Icon
8/12/2024SkyOak Wealth LLC15,000$0.15M0.0%N/A0.009%Search for SEC Filing on Google Icon
8/12/2024Amalgamated Bank2,910$29K0.0%+472.8%0.002%Search for SEC Filing on Google Icon
8/3/2024TD Asset Management Inc144,994$1.43M0.0%+31.6%0.091%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers103,258$1.02M0.0%+488.3%0.065%Search for SEC Filing on Google Icon
7/29/2024Principal Financial Group Inc.16,878$0.17M0.0%N/A0.011%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp235,593$2.32M0.0%+474.1%0.148%Search for SEC Filing on Google Icon
7/12/2024SG Americas Securities LLC57,607$0.57M0.0%N/A0.036%Search for SEC Filing on Google Icon
5/17/2024Artal Group S.A.2,924,052$40.21M1.0%+14.5%1.833%Search for SEC Filing on Google Icon
5/16/2024Kennedy Capital Management LLC136,828$1.88M0.0%N/A0.086%Search for SEC Filing on Google Icon
5/15/2024Baker BROS. Advisors LP633,851$8.72M0.1%N/A0.397%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD752,924$10.35M0.0%N/A0.472%Search for SEC Filing on Google Icon
5/14/2024Nan Fung Group Holdings Ltd63,315$0.87M0.8%N/A0.040%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.334,330$4.60M0.0%-12.2%0.210%Search for SEC Filing on Google Icon
5/3/2024Callan Capital LLC204,987$2.82M0.2%N/A0.129%Search for SEC Filing on Google Icon
5/1/2024Auour Investments LLC105,087$1.45M0.5%N/A0.066%Search for SEC Filing on Google Icon
4/23/2024Addis & Hill Inc314,821$4.19M3.6%N/A0.198%Search for SEC Filing on Google Icon
4/22/2024Windmill Hill Asset Management Ltd26,121$0.36M0.1%N/A0.016%Search for SEC Filing on Google Icon
2/14/2024Avidity Partners Management LP1,990,632$33.94M1.2%+10.6%1.304%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC2,558$44K0.0%N/A0.002%Search for SEC Filing on Google Icon
2/6/2024Amalgamated Bank1,709$29K0.0%N/A0.001%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Neumora Therapeutics logo
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; and NMRA-266, which is in the phase 1 clinical trial for the treatment of schizophrenia and other neuropsychiatric disorders. In addition, its preclinical phase product includes NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.
Read More on Neumora Therapeutics

Today's Range

Now: $1.28
Low: $1.27
High: $1.43

50 Day Range

MA: $1.85
Low: $1.28
High: $2.58

52 Week Range

Now: $1.28
Low: $1.26
High: $17.19

Volume

913,612 shs

Average Volume

1,419,555 shs

Market Capitalization

$207.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.59

Who are the company insiders with the largest holdings of Neumora Therapeutics?

Neumora Therapeutics' top insider shareholders include:
  1. Amgen Inc (Major Shareholder)
  2. Arch Venture Partners Xii, Llc (Major Shareholder)
  3. Kristina Burow (Director)
  4. Robert A Lenz (Insider)
  5. Joshua Pinto (CFO)
  6. Joshua Pinto (President)
  7. Michael Lee Milligan (Insider)
  8. Matthew K Fust (Director)
  9. Henry O Gosebruch (CEO)
Learn More about top insider investors at Neumora Therapeutics.

Who are the major institutional investors of Neumora Therapeutics?

Neumora Therapeutics' top institutional investors include:
  1. Softbank Group CORP. — 4.05%
  2. T. Rowe Price Investment Management Inc. — 3.10%
  3. Vanguard Group Inc. — 2.83%
  4. Capital International Investors — 2.29%
  5. Geode Capital Management LLC — 1.22%
  6. Point72 Asset Management L.P. — 0.00%
Learn More about top institutional investors of Neumora Therapeutics stock.

Which institutional investors are selling Neumora Therapeutics stock?

In the last quarter, NMRA stock was sold by these institutional investors:
  1. Softbank Group CORP.
  2. Orbimed Advisors LLC
  3. Price T Rowe Associates Inc. MD
  4. Soros Capital Management LLC
  5. T. Rowe Price Investment Management Inc.
  6. Addis & Hill Inc
  7. Candriam S.C.A.
  8. The Manufacturers Life Insurance Company
During the previous year, company insiders that have sold Neumora Therapeutics company stock include:
  1. Amgen Inc (Major Shareholder)
  2. Arch Venture Partners Xii, Llc (Major Shareholder)
  3. Kristina Burow (Director)
  4. Robert A Lenz (Insider)
  5. Joshua Pinto (CFO)
Learn More investors selling Neumora Therapeutics stock.

Which institutional investors are buying Neumora Therapeutics stock?

Within the previous quarter, NMRA stock was purchased by institutional investors including:
  1. Capital International Investors
  2. Point72 Asset Management L.P.
  3. Caption Management LLC
  4. Millennium Management LLC
  5. LMR Partners LLP
  6. Stempoint Capital LP
  7. Schonfeld Strategic Advisors LLC
  8. JPMorgan Chase & Co.
Within the previous year, these company insiders have bought Neumora Therapeutics stock:
  1. Amgen Inc (Major Shareholder)
  2. Arch Venture Partners Xii, Llc (Major Shareholder)
  3. Kristina Burow (Director)
  4. Robert A Lenz (Insider)
Learn More investors buying Neumora Therapeutics stock.